Current advances in biomarkers for targeted therapy in triple-negative breast cancer

Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...

全面介绍

Saved in:
书目详细资料
Main Authors: Brett Fleisher, Charlotte H. Clarke, Sihem Ait‐Oudhia
格式: Revisão
语言:英语
出版: 2016
在线阅读:https://doi.org/10.2147/bctt.s114659
https://www.dovepress.com/getfile.php?fileID=32807
标签: 添加标签
没有标签, 成为第一个标记此记录!